期刊文献+

比伐卢定氨基酸组成比测定方法的改进

Improvement of the method for determination of amino acids in Bivalirudin
下载PDF
导出
摘要 目的改进了比伐卢定氨基酸组成比测定方法。方法采用C18(250 mm×4.6 mm,5μm)色谱柱;流动相A为磷酸盐缓冲液,流动相B为60%乙腈,梯度洗脱;柱温:37℃;流速:1.4 mL/min;检测波长为248 nm。结果各氨基酸回收率为95.1%~98.3%,RSD为0.8%~1.2%。结论此法简便灵敏,结果准确可靠,可用于比伐卢定氨基酸组成比的测定。 Purpose To improve the method for the determination of amino acids in Bivalirudin.Methods The C18(250 mm×4.6 mm,5 μm) column was used.The phosphate buffer was used as mobile phase A,60% acetonitrile was used as mobile phase B and the temperature of column was 37 ℃.The flow rate was 1.4 mL/min and the detective wavelength was 248 nm.Results The average recovery was 95.1%~98.3% and RSD was 0.8%~1.2%.Conclusion The method is simple,sensitive and accurate.It can be used for the determination of amino acids in Bivalirudin.
作者 陈华
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2010年第5期338-340,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 比伐芦定 氨基酸组成比 高效液相色谱 Bivalirudin amino acids HPLC
  • 相关文献

参考文献5

二级参考文献32

  • 1崔莉,谭树华,章良,吴梧桐.重组水蛭素Ⅲ的分离纯化与鉴定[J].中国药科大学学报,2005,36(1):78-81. 被引量:12
  • 2丁有学,张翊,郭莹,韩春梅,刘兰,饶春明,王军志.重组水蛭素生物学活性检测参考品的制备和标定[J].中国生物制品学杂志,2005,18(6):498-500. 被引量:3
  • 3潘贺,刚宏林,王志国.水蛭素及重组水蛭素的应用研究概况[J].中医药学报,2006,34(2):60-62. 被引量:10
  • 4韦利军,郭昱,吴梧桐,章良,王耀方.重组水蛭素Ⅲ的质量控制标准研究[J].药物生物技术,2006,13(5):343-346. 被引量:1
  • 5傅中平,周吉燕,王富军.苦瓜中胰蛋白酶抑制剂活性的测定方法研究[J].食品与药品,2007,9(04A):14-17. 被引量:6
  • 6BITTL JA, CHAITMAN BR, FEIT F,et al. Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study[J]. Am Heart J, 2001,142(6) :952 -959.
  • 7LINOFF AM, BITTL JA, HARRINGTON RA,et al. Bivalirudin and provisional glycoprotein lib/Ilia blockade compared with heparin and planned glycoprotein lib/Ilia blockade during percutaneous coronary intervention : REPLACE-2 randomized trial [ J ]. JAMA, 2003,289(7 ) :853 - 863.
  • 8GIBSON CM, MORROW DA, MURPHY SA,et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention mierovascular dysfunction, isehemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial [ J ]. J Am Coll Cardiol, 2006,47 (12) :2364 - 2373.
  • 9MEDINA RP, FOTO D. The use of bivalirudin to prevent subacute thrombosis during drug-eluting stent implantation[ J]. J Invasive Cardiol, 2004,16 ( 5 ) : 236 - 239.
  • 10WHITE H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytie therapy for acute myocardial infarction: the HERO-2 randomised trial[ J ]. Lancet, 2001,358 (9296) : 1855 - 1863.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部